Patent · US Active

Genetically modified non-human animal with human or chimeric IL15

US11234421B2 · kind B2 · utility

0Cited by

2References

22Claims

0Family size

Assignees

Biocytogen JiangSu Co., Ltd. · CN
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Meiling Zhang · Beijing, CN
Jiawei Yao · Beijing, CN
Chaoshe Guo · Beijing, CN
Yanan Guo · Beijing, CN
Yang Bai · Beijing, CN
Rui Huang · Beijing, CN
Lei Zhao · Addison, US

Key dates

Filing date	Sep 4, 2020
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Sep 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL15, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.